醣聯

+0.20 (+0.93%)最後更新 2026-09-11

台灣 · 上櫃 · 生技醫療業

21.8092成交張數–本益比2.88股價淨值比0.00%殖利率2026-09-11資料日期

ROE 與 ROA

近四季合計;近十年

每股淨值

元

負債比率

負債總額 / 資產總額

現金流量

單季,億元;自由現金流 = 營業現金流 + 資本支出(負值)

季度	資產總額(億)	母公司權益(億)	負債比率	流動比率	每股淨值	ROE(近四季)	ROA(近四季)	營業現金流(億)	自由現金流(億)
2026Q2	14	9	38.9%	10.45	7.56	-29.3%	-20.3%	-0.4	-0.4
2026Q1	15	9	37.7%	9.79	8.05	-27.9%	-19.4%	-0.8	-0.8
2025Q4	16	10	36.8%	8.00	8.73	-23.2%	-16.4%	-0.6	-0.6
2025Q3	16	10	34.9%	11.24	9.34	-20.5%	-14.8%	-0.2	-0.2
2025Q2	13	10	22.0%	1.67	9.18	-18.8%	-15.0%	-0.5	-0.5
2025Q1	13	10	22.6%	1.62	9.23	-18.3%	-14.3%	-0.4	-0.5
2024Q4	13	10	20.5%	1.82	9.63	-19.8%	-16.0%	-0.6	-0.6
2024Q3	14	11	19.5%	2.03	10.21	-18.8%	-15.5%	-0.3	-0.4
2024Q2	14	12	18.4%	2.21	10.64	-19.3%	-16.0%	-0.8	-0.9
2024Q1	15	12	21.2%	2.14	11.07	-14.8%	-12.1%	-0.5	-0.6
2023Q4	16	13	17.8%	2.65	11.75	-13.1%	-10.9%	-0.2	-0.3
2023Q3	16	13	16.3%	3.03	12.34	-13.0%	-10.9%	-0.7	-0.7
2023Q2	17	14	15.9%	17.95	12.90	-13.8%	-10.9%	-0.4	-0.4
2023Q1	17	14	15.6%	20.37	12.91	-18.1%	-16.4%	-0.6	-0.6
2022Q4	17	14	15.8%	16.03	13.50	-15.7%	-14.1%	-0.4	-0.4
2022Q3	18	15	16.8%	18.50	14.54	-13.7%	-12.3%	-0.5	-0.5
2022Q2	18	13	25.6%	12.33	13.40	-12.7%	-10.8%	-0.5	-0.5
2022Q1	14	13	2.5%	13.13	13.61	-11.4%	-11.1%	-0.3	-0.3
2021Q4	14	14	2.6%	13.18	13.94	-11.9%	-11.6%	-0.2	-0.2
2021Q3	14	14	2.0%	19.54	14.41	-11.6%	-11.4%	-0.4	-0.5
2021Q2	15	14	1.9%	22.04	14.86	-9.9%	-9.4%	-0.3	-0.4
2021Q1	15	15	1.7%	26.57	15.33	-11.3%	-10.1%	-0.4	-0.4
2020Q4	16	15	2.2%	19.52	15.79	-11.5%	-11.2%	-0.3	-0.3
2020Q3	16	16	1.9%	23.94	16.55	-10.7%	-10.4%	-0.2	-0.2
2020Q2	16	15	8.0%	27.94	18.35	-15.0%	-14.3%	-0.3	-0.3
2020Q1	17	13	19.1%	31.46	16.38	-16.8%	-15.0%	-0.5	-0.6
2019Q4	13	13	2.4%	8.65	17.08	-17.4%	-17.1%	-0.3	-0.3
2019Q3	14	13	2.3%	9.27	17.38	-20.7%	-20.3%	-0.6	-0.6
2019Q2	14	14	1.8%	15.91	18.37	-18.2%	-17.9%	-0.5	-0.5
2019Q1	15	15	1.6%	22.54	19.31	-18.8%	-18.5%	-0.4	-0.4
2018Q4	16	15	1.9%	18.22	20.03	-18.8%	-18.5%	-0.4	-0.5
2018Q3	17	16	1.5%	28.77	21.33	-14.8%	-14.6%	-0.3	-0.3
2018Q2	17	17	1.5%	29.57	21.95	-13.5%	-13.3%	-0.4	-0.4
2018Q1	18	18	1.2%	39.59	23.20	-9.8%	-9.6%	-0.6	-0.6
2017Q4	19	18	1.4%	35.18	24.07	-7.5%	-7.4%	-0.3	-0.3
2017Q3	19	19	1.3%	37.02	24.23	-7.0%	-6.9%	-0.1	-0.2
2017Q2	20	19	2.0%	19.93	24.96	-6.3%	-6.1%	1.3	-0.7
2017Q1	20	20	2.1%	24.03	25.47	-5.6%	-5.5%	-0.2	-0.5
2016Q4	20	20	2.5%	20.75	25.80	–	–	-0.2	-0.4
2016Q3	21	20	2.3%	36.86	26.30	–	–	-0.1	-0.9